Document is current
Any future updates will be listed below
-
Authors
Piccininni, Marco http://orcid.org/0000-0002-1397-0060
Brinks, Ralph http://orcid.org/0000-0003-0961-6592
Rohmann, Jessica L. http://orcid.org/0000-0003-2420-5716
Kurth, Tobias http://orcid.org/0000-0001-7169-2620
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 29 March 2023
Accepted: 28 June 2023
First Online: 11 July 2023
Declarations
:
: As our study estimated quantities by using publicly available data from the GBD project and from two published population-based studies [CitationRef removed, CitationRef removed], ethics approval and consent to participate was not required.
: MP reports having received partial funding for this project from Novartis Pharma (granted to JLR) and being awarded, outside of this work, a research grant from the Center for Stroke Research Berlin (private donations) for a self-initiated project.RB reports no conflicts of interest.Outside of the work presented in this paper, TK reports having received research grants from the Gemeinsamer Bundesausschuss (G-BA – Federal Joint Committee, Germany), the Bundesministerium für Gesundheit (BMG – Federal Ministry of Health, Germany), and from the BMG (Federal Ministry of Health, Germany). He further has received personal compensation from Eli Lilly and Company, Teva Pharmaceuticals, TotalEnergies S.E., the <i>BMJ</i>, and <i>Frontiers</i>. JLR reported receiving a grant from Novartis Pharma for conducting this self-initiated research project.
